Severe thrombotic manifestations of COVID-19 are thought to be due to the ability of severe acute respiratory syndrome coronavirus 2 to invade endothelial cells through the angiotensin-converting enzyme 2 (ACE-2). This evidence concerns the gene ACE2 and COVID-19.